Complete Rescue of Lipoprotein Lipase–Deficient Mice by Somatic Gene Transfer of the Naturally Occurring LPLS447XBeneficial Mutation

CJD Ross,GQ Liu,JA Kuivenhoven,J Twisk,J Rip,W van Dop,KJDA Excoffon,SME Lewis,JJ Kastelein,MR Hayden

DOI: https://doi.org/10.1161/01.atv.0000176971.27302.b0

2005-01-01

Abstract:The naturally occurring human lipoprotein lipase S447X variant (LPLS447X) exemplifies a gain-of function mutation with significant benefits including decreased plasma triglycerides (TG), increased high-density lipoprotein (HDL) cholesterol, and reduced risk of coronary artery disease. The S447X variant may be associated with higher LPL catalytic activity; however, in vitro data supporting this hypothesis are contradictory. We wanted to investigate the in vivo mechanism by which the LPLS447Xvariant improves the lipid profile of S447X carriers. We conducted a functional assessment of human LPLS447Xcompared with LPLWTin mice. LPL variants were compared in the absence of endogenous mouse LPL in newborn LPL−/−mice by adenoviral-mediated gene transfer. LPL−/−mice normally exhibit severe hypertriglyceridemia and die within 48 hours of birth. LPLWTgene transfer prolonged the survival of mice up to 21 days. In contrast, LPLS447Xcompletely rescued 95% of the mice to adulthood and increased LPL catalytic activity in postheparin plasma 2.1-fold compared with LPLWTat day 3 (P=0.003). LPLS447Xalso reduced plasma TG 99% from baseline (P<0.001), 2-fold more than LPLWT, (P<0.01) and increased plasma HDL cholesterol 2.9-fold higher than LPLWT(P<0.01). These data provide in vivo evidence that the increased catalytic activity of LPLS447Ximproves plasma TG clearance and increases the HDL cholesterol pool compared with LPLWT.